focus -WSS

focus

author：knowledge 2025-09-27 09:58:03 - browse：15971

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： NIH nominee Bertagnolli will get October confirmation hearing

leisure time

WSS

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Crinetics acromegaly drug succeeds in late

Crinetics acromegaly drug succeeds in late

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

hotspot

focus

leisure time

Alkermes shareholders re

Snackable artificial intelligence, expert AI, and the pharma industry

The cancer drug shortage isn’t new — and neither are the solutions

House transparency, PBM reform bill gains bipartisan support

ChatGPT in medicine: STAT answers readers' burning questions

Crinetics acromegaly drug succeeds in late

State Dept. review finds Biden bears some blame for Afghanistan failures

Biden administration sends mixed signals on US soldier who crossed into North Korea

Guidelines to prevent youth baseball injuries need more muscle

US soldier in North Korean custody after crossing DMZ line

explore

Biden administration sends mixed signals on US soldier who crossed into North Korea

ALS advocates say criticism of new drugs misses bigger picture

Twill hunts for pharma partner to market its depression app

A rare thyroid diagnosis led to unexpected, all

Manchin plays down potential 3rd

15 die by electrocution after transformer explodes in northern India

leisure time

leisure time

focus

explore